I think my colleagues, Drs. Halperin and Neame, might be the best to respond to that.
As I say, there's quite a bit of coverage in the press right now in terms of making that decision. Do you provide it to the most vulnerable, the elderly, the marginalized populations, or do we identify the biggest spreaders, young people, etc., who are perhaps asymptomatic but spreading the disease? Do we give it to front-line health professionals? These are big questions for policy decision-makers.
Drs. Halperin or Neame, you may wish to jump in on this one.